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Summary
A combination of genetic factors and early life events
is thought to determine the vulnerability of an indivi-
dual to develop a complex neurodevelopmental disor-
der like schizophrenia. Pharmacogenetically selected,
apomorphine-susceptible Wistar rats (APO-SUS) dis-
play a number of behavioral and pathophysiological
features reminiscent of such disorders. Here, we re-
port microarray analyses revealing in APO-SUS rats,
relative to their counterpart APO-UNSUS rats, a re-
duced expression of Aph-1b, a component of the
-secretase enzyme complex that is involved in
multiple (neuro)developmental signaling pathways.
The reduced expression is due to a duplicon-based
genomic rearrangement event resulting in an Aph-1b
dosage imbalance. The expression levels of the other
-secretase components were not affected. However,
-secretase cleavage activity was significantly changed,
and the APO-SUS/-UNSUS Aph-1b genotypes segre-
gated with a number of behavioral phenotypes. Thus,
a subtle imbalance in the expression of a single, de-
velopmentally important protein may be sufficient to
cause a complex phenotype.
Introduction
We used the susceptibility of normal outbred Wistar
rats for the dopaminergic agonist apomorphine as a*Correspondence: g.martens@ncmls.ru.nlcriterion for the selection of two distinct types of in-
dividuals (Cools et al., 1990; Ellenbroek and Cools,
2002). Through systemic apomorphine administration
and long-term pharmacogenetic selections, we pro-
duced rats with a high or low susceptibility for this drug
(referred to as APO-SUS and APO-UNSUS rats, respec-
tively). Extensive phenotyping of the APO-SUS and
-UNSUS rats over the last 15 years has revealed differ-
ences in many aspects of behavior, neuroanatomy, and
their neurochemical, endocrine, and immune systems
(Cools et al., 1990; Ellenbroek and Cools, 2002). For
example, they differ in brain information processing
(prepulse inhibition and latent inhibition; Ellenbroek et
al., 1995), locomotor activity in response to novelty, and
fleeing and problem-solving behavior (Cools, 1988;
Cools et al., 1990). In addition, APO-SUS and -UNSUS
rats show changes in their hypothalamus-pituitary-
adrenal (HPA) axis response to stress (Rots et al., 1995);
their sensitivity to dopamimetic drugs (Ellenbroek et al.,
2000); their neuropeptide, steroid, and steroid receptor
levels (Cools et al., 1993; Rots et al., 1995, 1996); their
synaptic densities within hypothalamic nuclei (Mulders
et al., 1995); their TH2 cell contents; and their suscep-
tibilities to inflammatory and infectious diseases, va-
sorelaxation, and stress (Kavelaars et al., 1997). Cross-
breeding experiments have shown that genetic factors
play an important role in the development of the rat
model (Ellenbroek et al., 2000). Furthermore, the pro-
pensity of the model to develop the specific features
in adulthood is dependent on the timing and type of
stressors to which the rats have been exposed during
early life (Degen et al., 2004; Ellenbroek et al., 2000).
For example, when APO-SUS rats are reared from birth
on by APO-UNSUS mothers their susceptibility to apo-
morphine is significantly reduced, whereas such cross-
fostering has no effect on APO-UNSUS rats. Conversely,
a 24 hr separation of the pups from their mother early
in life enhances apomorphine susceptibility in APO-
UNSUS rats, while this maternal deprivation does not
affect APO-SUS rats (Ellenbroek et al., 2000). Interest-
ingly, 10 years after developing the original APO-SUS
and -UNSUS lines a separate, independent selection
and breeding procedure for apomorphine susceptibility
of Wistar rats resulted in replication of the APO-SUS
and -UNSUS lines that displayed similar features as the
original ones (Ellenbroek et al., 2000). In this study, we
examined the molecular basis of the differences be-
tween the APO-SUS and -UNSUS rats.
Results
Gene Expression Profiling of APO-SUS
and -UNSUS Hippocampus
In an attempt to understand the difference between
APO-SUS and -UNSUS rats at the molecular level, we
decided to determine for both lines the mRNA expres-
sion profiles of the hippocampus of postnatal day 9
(PND 9) and PND 60 rats using oligonucleotide and
cDNA microarrays. The hippocampus was selected be-
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498cause of its well-established physiological role in, for g
mexample, behavioral and HPA axis regulation (McEwen,
2002), the neurochemical differences observed in APO- a
cSUS and -UNSUS hippocampus (Ellenbroek and Cools,
2002), and the relative ease of its dissection. The time o
Apoint PND 9 was chosen because exposing APO-UNSUS
pups to a severe stressor at this stage causes the most (
dramatic effect on brain information processing later on
in life (Ellenbroek et al., 1998). At PND 60, the rats are E
just past their puberty and considered to be young C
adults, and at this age the clear phenotypic differences S
between APO-SUS and -UNSUS rats have been s
mapped (Cools and Ellenbroek, 2002; Ellenbroek and 2
Cools, 2002; Ellenbroek et al., 2000). The mRNA expres- d
sion profiling experiments revealed only one cDNA that e
met the preset criteria and could be confirmed by quan- r
titative reverse transcription-polymerase chain reaction s
(RT-PCR) (see Experimental Procedures for details). This v
transcript encodes the γ-secretase component Aph-1b, o
a predicted seven-transmembrane protein initially iden- r
tified through genetic screens in worms (Francis et al., S
2002; Goutte et al., 2002). e
d
sThe Aph-1b Gene in APO-SUS and -UNSUS Rats
dWe next considered the possibility that the different
oAph-1b mRNA expression levels in APO-SUS and
W-UNSUS were the result of a genomic DNA mutation.
iDatabase searches revealed that the rat (on chromo-
tsome 8q24) and mouse (on chromosome 9c) contain in
ftandem two Aph-1b-related copies (designated here as
aAph-1b and Aph-1b# with -1b downstream of -1b#),
neach consisting of six exons and spanningw20 kb and
separated by w24 kb. The single human Aph-1b gene
t(on chromosome 15q21.3) consists also of six exons,
ospansw28 kb, and represents the ortholog of rat/mouse
pAph-1b. Computational approaches to define potential
tintron-exon structure, comparative (rat/mouse) nucleo-
stide sequence analysis, and EST database searches
dgave no indications for the presence of a gene in the
2intergenic region of Aph-1b and -1b#. Southern blot and
tPCR analyses of genomic DNA revealed that all APO-
9UNSUS tested (n = 93) contained three Aph-1b-related
mcopies (here referred to as region III; Figure 1A), namely
aAph-1b#, chimeric Aph-1b/b# (consisting of exons 1–5
sof Aph-1b and exon 6# of Aph-1b#) and Aph-1b. Of 151
dAPO-SUS genotyped, 26% were homozygous for the
cduplicated genes (II/II), and 24% were homozygous for
Pchimeric Aph-1b#/b (consisting of exons 1#–5# of Aph-
1b# and exon 6 of Aph-1b) (I/I), whereas the remaining
50% were heterozygous harboring both the duplicated C
igenes and chimeric Aph-1b#/b (II/I) (Figure 1A). Inter-
estingly, we found that the first established APO- T
sUNSUS and -SUS lines (Ellenbroek et al., 2000) dis-
played the same genotypes (i.e., all of the original APO- W
γUNSUS tested were III/III, while all APO-SUS were II/II,
II/I, or I/I), indicating that the replication of the original A
uAPO-SUS/-UNSUS lines had resulted in the same Aph-
1b genotypic distribution. U
tA comparative nucleotide sequence analysis of rat
Aph-1b and -1b# showed a low degree of identity, ex- a
scept for the regions surrounding exons 5 and 5#, and
exons 6 and 6# (Figure 1B). A region of 1106 nucleotides m
acontaining exon 5/5# and identical between the twoenes was found to represent the junction area of chi-
eric Aph-1b#/b (Figure 1C). These results suggest that
n unequal crossing over (nonallelic homologous re-
ombination) between the identical regions around ex-
ns 5 and 5# (direct repeats) resulted in three in tandem
ph-1b-related copies (region III) and chimeric Aph-1b#/b
region I) (Figure 1D).
xpression of Aph-1b and the Other -Secretase
omponents in APO-SUS and -UNSUS Rats
ince a longitudinal study on hippocampus of postnatal
tages of APO-SUS and -UNSUS rats (0, 2, 4, 6, 9, 12,
2, 35, 60, and 100 days of age) showed the largest
ifferences in APO-SUS/-UNSUS Aph-1b-related mRNA
xpression at early postnatal stages (data not shown),
ats of PND 9 were used for subsequent expression
tudies. Quantitative RT-PCR on hippocampus RNA re-
ealed in PND 9 APO-SUS rats significantly lower levels
f Aph-1b-related mRNAs than in PND 9 APO-UNSUS
ats, namely a 2.3-, 3.2-, and 6.2-fold reduction in APO-
US (II/II), (II/I), and (I/I), respectively (Figure 2A). North-
rn blot analysis confirmed the quantitative RT-PCR
ata for hippocampus (Figure 2B) and furthermore
howed, relative to PND 9 APO-UNSUS rats, clearly re-
uced levels of Aph-1b-related mRNA expression in all
ther PND 9 APO-SUS (I/I) tissues tested (Figure 2C).
e were unable to reliably detect the Aph-1b protein,
n line with the inability of others to detect this seven-
ransmembrane protein (Gu et al., 2003) and despite the
act that we generated two additional antibodies
gainst two computationally selected and previously
ot chosen rat Aph-1b peptide regions.
Besides Aph-1b and its paralog Aph-1a, the γ-secre-
ase complex is presently thought to consist of three
ther physically interacting components, namely the
utative enzymatic core multipass transmembrane pro-
ein presenilin-1 or -2, the type I integral membrane pre-
enilin-associated glycoprotein nicastrin, and the small
ouble membrane-spanning protein Pen-2 (Fortini,
002; Francis et al., 2002; Goutte et al., 2002). Quantita-
ive RT-PCR revealed that in the hippocampus of PND
APO-UNSUS, and APO-SUS (II/II), (II/I), and (I/I), the
RNA levels of Aph-1a, presenilin-1 and -2, nicastrin,
nd Pen-2 were not significantly different or only
lightly affected (Figure 3A). Moreover, no significant
ifferences in the protein levels of these γ-secretase
omponents were observed in the hippocampus of
ND 9 APO-UNSUS and -SUS rats (Figure 3B).
leavage Activity of the -Secretase Enzyme
n APO-SUS and -UNSUS Rats
o examine the effect of the differential Aph-1b expres-
ion on γ-secretase enzyme activity, we performed
estern blot analysis of the cleavage products of the
-secretase substrates amyloid-β precursor protein
PP, p75 neurotrophin receptor (p75NTR), and neureg-
lin receptor ErbB4 in PND 2 APO-SUS (I/I) and APO-
NSUS (III/III) rat brain tissues (Figure 4). Since the ra-
ios of the Aph-1b and Aph-1amRNA levels greatly vary
mong rat tissues (data not shown), we decided to
tudy tissues with a high Aph-1b/-1amRNA ratio (pons/
edulla, ratio w3.8; olfactory bulb, ratio w2.9) as well
s tissues with a low ratio ([hypo]thalamus, ratio w0.9;
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499Figure 1. Aph-1b in APO-UNSUS and -SUS
Rats
(A) Schematic of the three Aph-1b-related
copies in the APO-UNSUS rat (referred to as
region III/III) and of the one or two gene cop-
ies in the APO-SUS rat (region II/II, II/I, or
I/I); black box, Aph-1b#; white box, Aph-1b;
white/black box, chimeric Aph-1b/b#; black/
white box, chimeric Aph-1b#/b. The results
are based on Southern blot and PCR analy-
ses of genomic DNA.
(B) Schematic of the degree of nucleotide
sequence identity between rat Aph-1b and
-1b#. The locations of exons 1/1# to 6/6# of
Aph-1b and -1b# are indicated by bars below
the schematic. The loop indicates the ab-
sence of 4145 nucleotides in Aph-1b. The re-
gion of 1106 nucleotides identical between
the two genes (surrounding exons 5 and 5#
and representing the site of recombination;
see under [D]) is indicated with an arrow
above the schematic.
(C) Alignment of the nucleotide sequences
surrounding exon 5 of rat Aph-1b, exon 5/5#
of chimeric Aph-1b#/b, and exon 5# of Aph-
1b#. The 1106 bp region identical between
the genes is indicated with an arrow (as in
[B] and [D]). The 5# and 3# regions flanking
the 1106 bp region in the chimeric gene are
identical to the corresponding regions in
Aph-1b# and -1b, respectively.
(D) Schematic of the genomic rearrangement
resulting from unequal crossing-over (inter-
chromosomal, nonallelic homologous re-
combination) between the in tandem Aph-
1b# and -1b (corresponding to region II in [A])
and leading to region III (Aph-1b#, chimeric
Aph-1b/b#, and Aph-1b) and region I (chi-
meric Aph-1b#/b). The 1106 bp regions (di-
rect repeat sequences) are depicted as ar-
rows, recombination is shown by the X, and
dots are used for clarity in the presentation.cerebellum, ratio w0.7). The first substrate examined
was the C-terminal fragment of APP (APP-CTF, also re-
ferred to as C83/C99), a well-defined direct γ-secretase
substrate (De Strooper et al., 1998). No differences in
the levels of APP-CTF were observed in the tissues
with a low Aph-1b/-1a ratio (cerebellum and [hypo]thal-
amus), while a significant increase was detected in the
olfactory bulb and pons/medulla (2.1- and 2.7-fold,
respectively) of I/I compared to III/III rats. This finding
indicates that γ-secretase cleavage activity was re-
duced in the APO-SUS (I/I) rats in tissues that normally
express relatively high Aph-1b levels (olfactory bulb and
pons/medulla). Cleavage by γ-secretase of the C-terminal
fragment of p75NTR (p75NTR-CTF) yields the p75NTR
intracellular domain (p75NTR-ICD; Kanning et al.,
2003). No major differences in the amounts of p75NTR-
ICD were found in the cerebellum, (hypo)thalamus, and
pons/medulla, whereas in the I/I rats the levels of this
product were significantly reduced in the olfactory bulb
(1.7-fold). Similarly, the levels of the third γ-secretase
substrate tested, the C-terminal fragment of ErbB4
(ErbB4-CTF), were significantly increased in the olfac-tory bulb of the I/I compared to the III/III rats (3.0-fold)
and not in the other three tissues. Thus, the reduced
expression of Aph-1b in the APO-SUS (I/I) rats has
decreased γ-secretase cleavage activity in a tissue-
dependent manner, i.e., only in tissues in which nor-
mally a high Aph-1b/-1a ratio occurs (pons/medulla
and olfactory bulb) could significant changes in activity
be detected.
Behavioral Phenotypes of the I/I, II/II, and III/III Rats
We next wondered whether the I/I, II/II, and III/III geno-
types segregated with specific behavioral phenotypes
and therefore performed a set of behavioral studies
with adult rats of the three sublines. We first tested the
susceptibility of the three lines for apomorphine by
scoring their gnawing responses and found that the III/
III rats (32 ± 20 gnaws per 45 min) were significantly
less susceptible for the drug than the II/II and I/I rats
(1141 ± 189 and 1370 ± 99 gnaws per 45 min, respec-
tively; Figure 5A). We then examined the explorative be-
havior of the three sublines on a large open field. III/III
rats habituated significantly faster (605 ± 76 s) than II/
Neuron
500Figure 2. Aph-1b mRNA Expression in the Hippocampus and Other
Tissues of PND 9 APO-UNSUS and -SUS Rats
(A) Quantitative RT-PCR on RNA extracted from hippocampus of
FPND 9 APO-UNSUS (U) and APO-SUS (S) (II/II), (II/I), and (I/I) rats.
nThe primer sets detected all Aph-1b-related mRNAs. Results (n =
(6 plus SEM) were normalized toward b-actin and are expressed as
aarbitrary units (AU). Asterisks denote significant differences
o(p < 0.02).
R(B) Northern blot analysis of RNA extracted from hippocampus of
ePND 9 APO-UNSUS and -SUS (II/II), (II/I), and (I/I) rats. The blot was
fhybridized with a full-length rat Aph-1b cDNA probe. As a control
(for RNA loading and integrity, 18S rRNA was used.
p(C) Northern blot analysis of RNA extracted from various tissues of
IPND 9 APO-UNSUS (III/III) and APO-SUS (I/I) rats. Tissues used
twere cerebellum (cer), olfactory bulb (olf), cortex (ctx), hippocam-
pus (hip), striatum (str), (hypo)thalamus (thal), pons/medulla (p/m),
spinal cord (spin), eye, testis (test), stomach (stom), small intestine
a(s.i.), large intestine (l.i.), lung, liver (liv), and thymus (thym). The blot
twas hybridized with a full-length rat Aph-1b cDNA probe. As a con-
ftrol for RNA loading and integrity, 18S rRNA was used.
nmaze therefore suggest that the I/I and II/II rats are lessigure 3. mRNA and Protein Expression of γ-Secretase Compo-
ents in the Hippocampus of PND 9 APO-UNSUS and -SUS Rats
A) Quantitative RT-PCR analysis of Aph-1a, presenilin-1 (PS1)
nd -2 (PS2), nicastrin (Nct), and Pen-2mRNAs in the hippocampus
f PND 9 APO-UNSUS (U) and APO-SUS (S) (II/II), (II/I), and (I/I) rats.
esults (n = 7 plus SEM) were normalized toward b-actin and are
xpressed as arbitrary units (AU). Asterisks denote significant dif-
erences (p < 0.02).
B) Western blot analysis of the Aph-1a, PS1, PS2, Nct, and Pen-2
roteins in the hippocampus of PND 9 APO-UNSUS and -SUS (II/
I), (II/I), and (I/I) rats. Results (n = 6 plus SEM) were normalized
oward β-actin and are expressed as arbitrary units (AU).III and I/I rats, which were found to hardly habituate
l(1548 ± 98 s and 1536 ± 123 s, respectively; the maxi-
mum score was 1800 s) (Figure 5B, upper panel). For
Dthe III/III, II/II, and I/I lines, a gradual increase in loco-
motor activity in the center of the open field was found,
Iwith the I/I rats being significantly more active than the
oIII/III rats (Figure 5B, lower panel), indicating a high ex-
pplorative activity of the I/I rats in a cueless environment.
cFinally, to assess novelty seeking in a stressful environ-
rment, the behaviors of the three sublines in the open
oversus the closed arms of the elevated plus maze were
dcompared. The time spent on the open relative to the
Sclosed arms gradually increased for the III/III, II/II, and
iI/I lines, with a significant difference between the III/III
erats (8.0 ± 3.5) and the II/II and I/I rat lines (22.6 ± 5.0
nand 30.5 ± 3.9, respectively) (Figure 5C, upper panel).
tThe III/III rats traveled significantly shorter distances on
rthe open relative to the closed arms than the II/II or I/I
srats (Figure 5C, middle panel). Furthermore, the number
vof entries into the open versus the closed arms grad-
oually increased for the III/III, II/II, and I/I rats and was
osignificantly different between the III/III and I/I rats (Fig-
ture 5C, lower panel). The results of the elevated plusnxious and more active than the III/III rats. Together,
he results of the apomorphine susceptibility, open
ield, and elevated plus maze tests indicate that a
umber of behavioral phenotypes of the III/III, II/II, and
/I rats segregated with the genotypes of the three sub-
ines.
iscussion
n this study, we explored the molecular genetic basis
f APO-SUS rats that have a complex phenotype dis-
laying a number of behavioral, neurochemical, endo-
rinological, and immunological disturbances. Microar-
ay analyses revealed the differential expression of only
ne gene (Aph-1b) that was found to be due to a gene
osage effect with one or two Aph-1b copies in APO-
US and three copies in APO-UNSUS rats. The dosage
mbalance was caused by an unequal crossing over
vent, and the site of recombination was established,
amely between direct repeats (a segmental duplica-
ion) within the Aph-1b locus in the rat genome. This
ecombination event is reminiscent of recently de-
cribed human chromosomal rearrangements that in-
olve segmental duplications, cause dosage imbalance
f genetic material, and result in so-called genomic dis-
rders; segmental duplications comprise at least 5% of
he human genome, and duplicon-based genomic re-
arrangements appear to occur de novo at a frequency
Aph-1b Gene Dosage Effect in Complex Rat Phenotype
501Figure 4. Western Blot Analysis of the Cleavage Products of
γ-Secretase Substrates in PND 2 APO-UNSUS and -SUS Rat
Tissues
The cleavages of three direct γ-secretase substrates were investi-
gated by analyzing the levels of C-terminal fragments of amyloid-β
precursor protein (APP-CTF), p75 neurotrophin receptor (p75NTR-
CTF), and neuregulin receptor ErbB4 (ErbB4-CTF) in the olfactory
bulb (olf), pons/medulla (p/m), cerebellum (cer), and (hypo)thala-
mus (thal) of APO-UNSUS (U) (III/III) and APO-SUS (S) (I/I) rats. In-
cluded for p75NTR is the analysis of its intracellular domain
(p75NTR-ICD), a γ-secretase cleavage product. Tubulin was used
for normalization. Levels were significantly different between the
I/I and III/III rats for APP-CTF, p75NTR-ICD, and ErbB4-CTF in the
olfactory bulb and for APP-CTF in the pons/medulla (p < 0.05; n =
3, with the three rats from different nests).of 0.7–1 in every 1000 births (Ji et al., 2000). However, in
contrast to the situation in rodents, the human genome
harbors only a single Aph-1b.
In addition to the finding of its differential expression,
a direct link between Aph-1b and the observed charac-
teristics of the APO-SUS and -UNSUS rat lines is sug-
gested by the fact that the replicated APO-SUS and
-UNSUS lines displayed similar differences in behavior
and Aph-1b copy numbers as the original lines. Fur-
thermore, the results of our behavioral tests indicated
that the Aph-1b genotypes segregate with a number of
behavioral APO-SUS and -UNSUS phenotypes. Aph-1b
and its paralog Aph-1a represent components of the
γ-secretase enzyme complex and, together with Pen-2,
are thought to be involved in the regulation of γ-secre-
tase activity by modulating the biogenesis of preseni-
lin-nicastrin complexes (De Strooper, 2003). We have
indeed found that in the APO-SUS rats the lower Aph-
1b levels had changed γ-secretase cleavage activity.
The γ-secretase enzymatic machinery mediates intra-
membranous proteolytic cleavage of at least 14 type I
transmembrane proteins that are thought to be in-
volved in a complicated network of signaling pathways
affecting many biological processes with a variety of
physiological effects, especially during early (neuro)de-
velopment (De Strooper, 2003; Fortini, 2002). Taken al-
together, the results show that the reduced expression
of Aph-1b underlies the APO-SUS phenotype. Thus, a
subtle imbalance in the expression of a single gene pro-
duct that is involved in a wide variety of developmental
signaling pathways may well constitute the molecular
basis of a complex phenotype that is generally believed
to have a multifactorial background.
Experimental Procedures
Animals
Systemic administration of apomorphine (1.5 mg/kg s.c.) was used
to select rats with a high or low susceptibility to this drug (APO-
SUS and APO-UNSUS rats, respectively); the behavior was quanti-Figure 5. Behavioral Phenotypic Analysis of Adult Rats with I/I, II/
II, and III/III Genotypes
(A) Apomorphine susceptibility test for gnawing behavior. Following
1.5 mg/kg apomorphine (s.c.) injection, the gnawing scores of III/
III, II/II, and I/I rats were recorded for 45 min (n = 12, 10, and 11,
respectively; plus SEM).
(B) Open field test for explorative behavior. III/III, II/II, and I/I rats
were analyzed on a large open field for 30 min. (Upper panel) The
time period the rats have used to habituate (i.e., cease their loco-
motor activity for 90 s); (lower panel) the locomotor activity in the
center of the open field (n = 11, 10, and 10, respectively; plus SEM).
(C) Elevated plus maze test for novelty seeking in a stressful envi-
ronment. The walking patterns of III/III, II/II, and I/I rats in the open
and closed arms of the elevated plus maze were analyzed for 10
min. (Upper panel) The time spent in the open relative to the closed
arms; (middle panel) the relative distance traveled in the open rela-
tive to the closed arms; (lower panel) the number of entries into the
open relative to the closed arms (n = 11, 16, and 10, respectively;
plus SEM). Asterisks denote significant differences (*p < 0.05;
**p < 0.01; ***p < 0.001).fied with the Ungerstedt box, and the rats were classified on the
basis of their gnawing scores (APO-SUS, >500 gnaws in 45 min;
APO-UNSUS, <10 gnaws in 45 min) to select female and male rats
for breeding the two distinct lines (Cools et al., 1990). We have
avoided brother-sister pairings and used a specific procedure that
was aimed at selectively breeding for apomorphine susceptibility,
while otherwise maintaining the genotypic heterogeneity of the ini-
tial Wistar strain. For the present study, we used APO-SUS and
-UNSUS rats of the 13th to the 20th generation; genotyping of the
original APO-SUS and -UNSUS lines was on rats of the 32nd gener-
ation. For the behavioral tests, adult male rats (PND 60–PND 70)
were used, and separate I/I, II/II, and III/III lines were generated by
PCR analysis of genomic DNA with specific primers and intermat-
ing each of the genotypes. The I/I and II/II sublines were produced
from the APO-SUS line. Following its creation in 1994, the APO-
SUS line has been maintained for 19 generations by random breed-
ing. When we recently discovered the genomic recombination
event reported here, we decided to select APO-SUS rats homozy-
gous for one or two Aph-1b copies. The two rat populations were
then intermated separately, resulting in the generation of the two
APO-SUS sublines (I/I and II/II). Since no selection other than for
Aph-1b homozygosity was applied, apart from the Aph-1b locus
these sublines have highly similar general genetic backgrounds.
Rats were bred and reared in the Central Animal Facility of the
Radboud University Nijmegen under approved animal protocols
and in accordance with institutional guidelines.
Microarray Experiments
For mRNA expression profiling, hippocampi were dissected from
fresh brains of PND 9 and PND 60 APO-SUS and -UNSUS rats, and
the tissues were frozen in liquid nitrogen. Furthermore, hippocampi
Neuron
502were isolated from PND 60 APO-SUS and -UNSUS rats 3 hr after f
ethey were injected with apomorphine (1.5 mg/kg, s.c.). Total RNA
was prepared with the Trizol reagent (Gibco BRL Life Technol-
ogies), and RNAs from five hippocampi were pooled and used in G
the microarray analyses. The PND 9 hippocampal samples were A
analyzed using Affymetrix high-density oligonucleotide arrays (Rat b
Genome Set U34A containing w7000 full-length sequences and c
w1000 EST clusters randomly selected from Rattus norvegicus da- c
tabase sequences) according to the manufacturer’s recommenda- V
tions. Briefly, total RNA was purified on RNeasy columns (Qiagen), o
and 20 g RNA was reverse transcribed (Superscript II; GibcoBRL m
Life Technologies) using a T7-dT24 primer (GenSet). Following se- D
cond-strand synthesis, the double-stranded cDNA was used in an p
in vitro transcription reaction to generate biotinylated cRNA. Puri- p
fied, fragmented cRNA (10 g) was hybridized onto the Affymetrix
arrays for 16 hr at 45°C. Standard posthybridization washes and N
double-stain protocols were performed on a GeneChip Fluidics T
Station 400 (Affymetrix). Arrays were scanned on a Hewlett Packard I
Gene Array scanner and analyzed using Microarray Suite version U
5.0 software. For the PND 60 hippocampal samples, we used the r
Incyte high-density cDNA microarrays (Rat NeuroGEM 2.02 con- s
taining 8478 Sprague-Dawley rat nervous system cDNAs repre- p
senting 6746 different genes). Isolation of mRNA, conversion to Cy3
or Cy5 fluorescently labeled cDNA, hybridization, and scanning W
were performed as described previously (Yue et al., 2001), and the P
data were analyzed with GEMTools 2.5 software. All microarray ex- v
periments were performed with biological duplicates. With the oli- t
gonucleotide microarrays, no differences were found that met the A
criteria (a difference in expression between PND 9 APO-SUS and T
-UNSUS hippocampus of >1.3-fold), while seven cDNAs were m
found to be differentially expressed on the cDNA arrays (i.e., >1.5- a
fold difference between PND 60 APO-SUS and -UNSUS hippocam- r
pus). However, the mRNA expression levels of four of these were p
not significantly different between APO-SUS and -UNSUS rats r
upon validation of the microarray data by quantitative RT-PCR. The s
differences in expression of two cDNAs (encoding transthyretin and A
prostaglandin D-synthase) were confirmed by the validation analy- 1
ses but resulted from their expression in contaminating choroid d
plexus (dissection artifact during the isolation of the hippocampus). S
The Aph-1b transcript met the criteria, and its w1.6-fold reduction 1
in hippocampal mRNA expression in basal and apomorphine- a
treated PND 60 APO-SUS relative to APO-UNSUS rats found on a
the cDNA microarrays was confirmed by quantitative RT-PCR b
(2.2 ± 0.3- and 3.1 ± 0.8-fold reduction in basal and apomorphine- r
treated PND 60 APO-SUS rats, respectively; n = 9). The Aph-1b
transcript was not represented on the oligonucleotide microarrays. B
F
mQuantitative RT-PCR
iFor quantitative RT-PCR, first-strand cDNA was prepared from 2 µg
wof DNase I-treated total RNA (isolated as described above) using
cSuperscript II reverse transcriptase (Invitrogen). PCR samples con-
ctained 1× SYBR Green buffer; 3 mM MgCl2; 0.4 mM dUTP; 0.2 mM
Leach of dATP, dCTP, and dGTP; 0.6 U AmpliTaq Gold (all from Ap-
aplied Biosystems); 0.6 µM each oligonucleotide primer (Biolegio)
tand 1/20 synthesized cDNA in a 25 µl volume. Quantitative PCR
wwas performed in a PE GeneAmp 5700 apparatus with conditions
sas follows: 10 min at 94°C, then 40 cycles of 15 s at 94°C, 30 s at
c60°C, and 1 min at 72°C. b-actin was amplified from all samples to
pnormalize expression. A control (no template) was included for
teach primer set. Data sets were analyzed with Sequence Detection
System 1.3 software.
SThe following primers were used: Aph-1b-related (448–671), 5#-
DGTGATTCTCCTCAGTTCTTCCTTAATTC and 5#-GCCCATGAGCAC
fCATGATTATAT; Aph-1a-related (547–670), 5#-AGAGGAGACGGTAC
aTGGGCTTT and 5#-ATGGAAACGGTGACTGCATAGA; presenilin-1
c(259–378), 5#-GTTCCTGTGACCCTCTGCATG and 5#-GCCTACAGT
uCTCGGTGTCTTCTG; presenilin-2 (1093–1218), 5#-GGAGACTTCAT
CTTCTACAGCGTTCT and 5#-GAGCAGCAGGAGGGTGAGAC; nic-
astrin (504–622), 5#-TGGCTTGGCTTATGACGACTT and 5#-TCGGT
AGCAGAGCCATTCTG; Pen-2 (14–162), 5#-GGGTGTCCAATGAGGA
GAAGTT and 5#-TTGATTTGGCTCTGCTCTGTGTA; b-actin (346–
435), 5#-CGTGAAAAGATGACCCAGATCA and 5#-AGAGGCATACAG W
fGGACAACACA; numbers in parentheses are nucleotide positionsrom start ATG. All PCR products were generated over intron-
xon boundaries.
enomic DNA Analysis
PO-SUS and -UNSUS rats were genotyped by extensive Southern
lot analysis and PCR screening of genomic tail DNA (primers and
onditions available on request). Comparative analysis of the nu-
leotide sequences of rat Aph-1b and -1b# was performed with
ector NTI. The nucleotide sequences surrounding exons 5 and 5#
f Aph-1b and -b#, respectively, and of the junction area within chi-
eric Aph-1b#/b, were determined by PCR analysis of genomic
NA from APO-UNSUS and -SUS (II/II) and (I/I) rats using specific
rimers and subsequent nucleotide sequence analysis of the PCR
roducts.
orthern Blotting
otal RNA from hippocampus of PND 9 APO-UNSUS and -SUS (II/
I), (II/I), and (I/I) rats, and from various tissues of PND 9 APO-
NSUS and -SUS (I/I) rats was isolated as described above, sepa-
ated on gel (10 µg per lane), blotted, and hybridized according to
tandard procedures with a full-length 798 bp rat Aph-1b cDNA
robe detecting all Aph-1b-related mRNAs (w1.3 kb).
estern Blotting
rotein extractions and immunoblottings were performed as pre-
iously described (Herreman et al., 2003). To examine Aph-1b pro-
ein expression, multiple tissue extraction methods and a variety of
PO-SUS/-UNSUS and mouse tissues and cell lines were used.
he polyclonal antibodies against presenilin-1 and nicastrin (Herre-
an et al., 2003), against presenilin-2 (Zymed Laboratories Inc.),
nd against Pen-2 and Aph-1a (Nyabi et al., 2003) were raised in
abbits. The antibodies against Aph-1b were directed against the
eptides CLVRVITDNRDGPV and CVAGGSRRSL and generated in
abbits (BioGenes GMBH, Germany). To examine γ-secretase sub-
trate cleavage, antibodies were used against the C terminus of
PP (C87, polyclonal antibody directed toward the most C-terminal
2 amino acids of APP and generated in rabbits), p75NTR (Maha-
eo et al., 1994), and ErbB4 (C-18; Santa Cruz Biotechnology,
anta Cruz, CA), and against β-tubulin (E7; Chu and Klymkowsky,
989) on brain tissue samples from three (I/I) rats of different nests
nd three (III/III) rats of different nests. Sample preparations for the
nalysis of APP, p75NTR, and ErbB4 were performed as described
y Herreman et al. (2003), Jung et al. (2003), and Ni et al. (2001),
espectively.
ehavioral Analysis
or the apomorphine susceptibility test, rats were injected with 1.5
g/kg apomorphine (s.c.), and their gnawing behavior was tested
n an Ungerstedt box (Cools et al., 1990). In the open field test, rats
ere placed in the center of an elevated open field of 160 × 160
m without walls. The open field was artificially subdivided into a
entral part (40 × 40 cm) and a peripheral area (16 cm in width).
ocomotor behavior was recorded for 30 min with a computerized
utomated tracking system, and the habituation time (defined as
he time until the rat stopped locomotor activity for at least 90 s)
as measured (Cools et al., 1990). The elevated plus maze con-
isted of a Plexiglas four-armed maze with two open and two
losed arms (10 × 50 cm). Each rat was placed in the center of the
lus maze facing a closed arm, and the rat was allowed to explore
he maze for 5 min.
tatistics
ata are presented as mean ± SEM. Statistical evaluation was per-
ormed using one-way analysis of variance (ANOVA) followed by
Bonferroni t test where three groups were compared. For the
omparison of two groups, the Student’s t test was employed. Val-
es of p < 0.05 were considered statistically significant.
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